DE69837666D1 - Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus - Google Patents

Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus

Info

Publication number
DE69837666D1
DE69837666D1 DE69837666T DE69837666T DE69837666D1 DE 69837666 D1 DE69837666 D1 DE 69837666D1 DE 69837666 T DE69837666 T DE 69837666T DE 69837666 T DE69837666 T DE 69837666T DE 69837666 D1 DE69837666 D1 DE 69837666D1
Authority
DE
Germany
Prior art keywords
immunomatic
antigenes
antibodies
synthetic
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69837666T
Other languages
English (en)
Other versions
DE69837666T2 (de
Inventor
Patrick F Coleman
Su Peter Chong-Dug
Nobuo Monji
Carol-Ann Cole
Alice Kamp Goshorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Application granted granted Critical
Publication of DE69837666D1 publication Critical patent/DE69837666D1/de
Publication of DE69837666T2 publication Critical patent/DE69837666T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69837666T 1997-08-01 1998-07-31 Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus Expired - Lifetime DE69837666T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90482697A 1997-08-01 1997-08-01
US904826 1997-08-01
PCT/US1998/016160 WO1999006599A1 (en) 1997-08-01 1998-07-31 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus

Publications (2)

Publication Number Publication Date
DE69837666D1 true DE69837666D1 (de) 2007-06-06
DE69837666T2 DE69837666T2 (de) 2007-12-27

Family

ID=25419850

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69841664T Expired - Lifetime DE69841664D1 (de) 1997-08-01 1998-07-31 Synthetisches Antigen zum Nachweis von HIV-immunreaktiven Antikörpern
DE69837666T Expired - Lifetime DE69837666T2 (de) 1997-08-01 1998-07-31 Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69841664T Expired - Lifetime DE69841664D1 (de) 1997-08-01 1998-07-31 Synthetisches Antigen zum Nachweis von HIV-immunreaktiven Antikörpern

Country Status (9)

Country Link
US (1) US7144697B1 (de)
EP (2) EP1878805B1 (de)
JP (2) JP4166940B2 (de)
AT (2) ATE467690T1 (de)
AU (1) AU753780B2 (de)
CA (1) CA2298438C (de)
DE (2) DE69841664D1 (de)
ES (2) ES2344926T3 (de)
WO (1) WO1999006599A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
JP2005514582A (ja) * 2001-04-30 2005-05-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 自動化ハイブリダイゼーション用の試薬および方法
CA2634992C (en) 2001-07-05 2012-10-16 Novartis Vaccines And Diagnostics, Inc. Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2568981A1 (en) * 2006-02-24 2007-08-24 University Of Manitoba Integrase-derived hiv-inhibiting agents
JP2015535841A (ja) * 2012-09-27 2015-12-17 アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． シュマーレンベルグウイルス（ｓｂｖ）の検出方法及びキット
US20210317192A9 (en) * 2019-05-29 2021-10-14 Massachusetts Institute Of Technology Hiv-1 specific immunogen compositions and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519005B1 (fr) 1981-12-29 1985-10-25 Pasteur Institut Fragments d'adn marques a l'une au moins de leurs extremites par des ribonucleotides modifies reconnaissables par des molecules affines et procede pour realiser une analyse de tels fragments d'adn
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US5580739A (en) * 1986-01-22 1996-12-03 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US5206136A (en) * 1986-11-19 1993-04-27 Genetic Systems Corporation Rapid membrane affinity concentration assays
JP2948823B2 (ja) * 1987-01-16 1999-09-13 アンステイテユ・パストウール ヒト免疫不全レトロウィルス（ｈｉｖ）関連抗原性ペプチド、そのウィルス感染の検出及びワクチンへの使用
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
AU5184190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
RU2043411C1 (ru) * 1992-01-05 1995-09-10 Биотехнологическая компания "Биосервис" Набор для определения антител к вирусу иммунодефицита человека первого и второго типов
RU2085586C1 (ru) * 1992-02-28 1997-07-27 Биотехнологическая компания "Биосервис" Полипептид 1106, предназначенный для определения антител к вирусу иммунодефицита человека первого типа, фрагмент днк н 1106, кодирующий полипептид 1106, рекомбинантная плазмидная днк рн 1106, кодирующая полипептид 1106, штамм бактерий escherichia coli - продуцент полипептида 1106
NZ263050A (en) * 1993-03-05 1997-11-24 Cytel Corp Compositions of immunogenic peptides with hla-a2.1 binding motifs

Also Published As

Publication number Publication date
EP1000177A4 (de) 2003-07-09
JP2001512037A (ja) 2001-08-21
EP1878805A3 (de) 2008-04-23
ATE467690T1 (de) 2010-05-15
WO1999006599A1 (en) 1999-02-11
AU753780B2 (en) 2002-10-31
US7144697B1 (en) 2006-12-05
EP1878805A2 (de) 2008-01-16
DE69837666T2 (de) 2007-12-27
ES2344926T3 (es) 2010-09-09
AU8686098A (en) 1999-02-22
EP1000177B1 (de) 2007-04-25
ATE360709T1 (de) 2007-05-15
DE69841664D1 (de) 2010-06-24
ES2286854T3 (es) 2007-12-01
JP4166940B2 (ja) 2008-10-15
JP2005139204A (ja) 2005-06-02
CA2298438A1 (en) 1999-02-11
EP1878805B1 (de) 2010-05-12
EP1000177A1 (de) 2000-05-17
CA2298438C (en) 2010-10-05

Similar Documents

Publication Publication Date Title
DE3650175D1 (de) Synthetische antigene zum nachweis von aids.
ES8708058A1 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
DE3752170D1 (de) Synthetisches Antigen zum Nachweis von mit AIDS in Zusammenhang stehenden Krankheiten
DE69030124D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
DE3587394D1 (de) Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder "acquired immune deficiency syndrome" (aids).
ATE109830T1 (de) Expression von virusproteinen mit immunologischer aktivität.
MX26715A (es) Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas.
DE69837666D1 (de) Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus
DE3850593D1 (de) Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten.
ATE176913T1 (de) Faser-hemagglutinin von b. pertussis
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
FI950516A (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
ATE57262T1 (de) Verfahren zum nachweis von proteinen und viren.
FI95726C (fi) Diagnostiset menetelmät ja määrityssarjat, joissa käytetään yhdistelmä-DNA-tekniikalla muodostettua hepatitis B -viruksen pinta-antigeenia
ATE236405T1 (de) Western blot test zur identifizierung von hcmv spezifische antiköpern
DE69033316D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C Virus
ATA71388A (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung
ATE62019T1 (de) Verfahren zur herstellung von hcmvglykoproteinen, antikoerper dagegen und hcmvvakzine und dazu zu verwendende rekombinante vektoren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition